Your browser doesn't support javascript.
loading
Milk extracellular vesicles accelerate osteoblastogenesis but impair bone matrix formation.
Oliveira, Marina C; Arntz, Onno J; Blaney Davidson, Esmeralda N; van Lent, Peter L E M; Koenders, Marije I; van der Kraan, Peter M; van den Berg, Wim B; Ferreira, Adaliene V M; van de Loo, Fons A J.
Affiliation
  • Oliveira MC; Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Nutrition, Nursing School, Universidade Federal de Minas Gerais Belo Horizonte, Minas Gerais, Brazil.
  • Arntz OJ; Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Blaney Davidson EN; Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van Lent PL; Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Koenders MI; Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van der Kraan PM; Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van den Berg WB; Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Ferreira AV; Department of Nutrition, Nursing School, Universidade Federal de Minas Gerais Belo Horizonte, Minas Gerais, Brazil.
  • van de Loo FA; Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Fons.vandeloo@radboudumc.nl.
J Nutr Biochem ; 30: 74-84, 2016 Apr.
Article in En | MEDLINE | ID: mdl-27012623
ABSTRACT
The claimed beneficial effect of milk on bone is still a matter for debate. Recently extracellular vesicles (EVs) that contain proteins and RNA were discovered in milk, but their effect on bone formation has not yet been determined. We demonstrated previously that bovine milk-derived EVs (BMEVs) have immunoregulatory properties. Our aim was to evaluate the effect of BMEVs on osteogenesis by mice and human mesenchymal stem cells (hMSCs). Oral delivery of two concentrations of BMEVs to female DBA/1J mice during 7weeks did not alter the tibia trabecular bone area; however, the osteocytes number increased. In addition, the highest dose of BMEVs markedly increased the woven bone tissue, which is more brittle. The exposure of hMSCs to BMEVs during 21days resulted in less mineralization but higher cell proliferation. Interestingly BMEVs reduced the collagen production, but enhanced the expression of genes characteristic for immature osteoblasts. A kinetic study showed that BMEVs up-regulated many osteogenic genes within the first 4days. However, the production of type I collagen and expression of its genes (COL1A1 and COL1A2) were markedly reduced at days 21 and 28. At day 28, BMEVs again lead to higher proliferation, but mineralization was significantly increased. This was associated with increased expression of sclerostin, a marker for osteocytes, and reduced osteonectin, which is associated to bone matrix formation. Our study adds BMEVs to the list of milk components that can affect bone formation and may shed new light on the contradictory claims of milk on bone formation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Bone Matrix Limits: Animals Language: En Journal: J Nutr Biochem Journal subject: BIOQUIMICA / CIENCIAS DA NUTRICAO Year: 2016 Document type: Article Affiliation country: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Bone Matrix Limits: Animals Language: En Journal: J Nutr Biochem Journal subject: BIOQUIMICA / CIENCIAS DA NUTRICAO Year: 2016 Document type: Article Affiliation country: Brazil